JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί VCEL

Are analysts right about Vericel (VCEL)?

Health Care Β· price $41.18 Β· median target $58.00 (+41%)
In short β€” Over the past 12 months, 42% of analyst price targets on Vericel turned out profitable, for an average return of +29% (across 55 timestamped calls). The current consensus is "Buy" with a median price target of $58.00 (+41% vs the current $41.18, from 3 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Vericel β€” Financials & fundamentals  Β·  If I had invested
Current price
$41.18
Median target (12 mo)
$58.00 +41%
Analyst accuracy (1 yr)
42%
Avg return / call (1 yr)
+29%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For Vericel, we replayed every analyst price target of the past 12 months and measured the real outcome: 42% were profitable, average return +29% (55 calls). At 3 months: +8% average return (48% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
HC Wainwright & Co.1850%+25%
Truist Securities922%+7%
BTIG771%+143%
Stephens & Co.743%+7%

Frequently asked questions

Is Vericel a buy right now?

The analyst consensus on Vericel (VCEL) is "Buy" (11 bullish, 0 bearish calls over 12 months). This is not advice: historically, 42% of their targets on this stock turned out profitable over 1 year.

What is Vericel's price target?

The median 12-month price target is $58.00 (+41% vs $41.18), ranging from $58.00 to $72.00 (3 analysts).

Are analysts accurate on Vericel?

Over 1 year, 42% of analyst targets on Vericel were profitable, for an average return of +29% (across 55 timestamped calls). This is JPI Invest's accuracy metric.

What is the Vericel stock forecast?

Analysts target a median of $58.00 within 12 months, i.e. +41% vs the current price. The most bullish targets $72.00, the most cautious $58.00.

What is the Vericel stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $58.00, +41%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (42%), and the stock's past trajectory.

Is Vericel overvalued?

Detailed valuation data for Vericel is available in the interactive analysis.

πŸ“Š See the full interactive analysis of Vericel β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.